moderna emergency use authorization

News

FDA, COVID and Moderna

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

STAT · 1d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

Just The News · 2d

In era of skepticism, FDA clears Moderna COVID vaccination for some kids up to 11 years old

ABC7 San Francisco1d

Moderna seeks emergency use authorization for Covid-19 vaccine for ...

NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said ...

StockStory.org on MSN2d

Why Moderna (MRNA) Stock Is Up Today

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

FDA, COVID and Moderna

Trending now